These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7877257)

  • 1. Analysis of the neurofibromatosis 2 gene in human breast and hepatocellular carcinomas.
    Kanai Y; Tsuda H; Oda T; Sakamoto M; Hirohashi S
    Jpn J Clin Oncol; 1995 Feb; 25(1):1-4. PubMed ID: 7877257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
    Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
    Lutchman M; Rouleau GA
    Cancer Res; 1995 Jun; 55(11):2270-4. PubMed ID: 7757975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation.
    Cheng JQ; Lee WC; Klein MA; Cheng GZ; Jhanwar SC; Testa JR
    Genes Chromosomes Cancer; 1999 Mar; 24(3):238-42. PubMed ID: 10451704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
    Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
    Bianchi AB; Hara T; Ramesh V; Gao J; Klein-Szanto AJ; Morin F; Menon AG; Trofatter JA; Gusella JF; Seizinger BR
    Nat Genet; 1994 Feb; 6(2):185-92. PubMed ID: 8162073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
    Yoo NJ; Park SW; Lee SH
    Pathology; 2012 Jan; 44(1):29-32. PubMed ID: 22081132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p300 gene alterations in colorectal and gastric carcinomas.
    Muraoka M; Konishi M; Kikuchi-Yanoshita R; Tanaka K; Shitara N; Chong JM; Iwama T; Miyaki M
    Oncogene; 1996 Apr; 12(7):1565-9. PubMed ID: 8622873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
    Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
    Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and distribution of NF2 mutations in schwannomas.
    Jacoby LB; MacCollin M; Barone R; Ramesh V; Gusella JF
    Genes Chromosomes Cancer; 1996 Sep; 17(1):45-55. PubMed ID: 8889506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
    Zhang LN; Zha XL; Yu Q; He JY
    Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.
    Huynh DP; Tran TM; Nechiporuk T; Pulst SM
    Cell Growth Differ; 1996 Nov; 7(11):1551-61. PubMed ID: 8930405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N; Seizinger BR
    Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.
    Sekido Y; Pass HI; Bader S; Mew DJ; Christman MF; Gazdar AF; Minna JD
    Cancer Res; 1995 Mar; 55(6):1227-31. PubMed ID: 7882313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
    Schipper H; Papp T; Johnen G; Pemsel H; Bastrop R; Müller KM; Wiethege T; Jaworska M; Krismann M; Schiffmann D; Rahman Q
    Int J Oncol; 2003 May; 22(5):1009-17. PubMed ID: 12684666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.
    Takahashi K; Kudo J; Ishibashi H; Hirata Y; Niho Y
    Hepatology; 1993 May; 17(5):794-9. PubMed ID: 8387946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.